 | • レポートコード：QFJ1-4209 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、エキソヌクレアーゼの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ATP産生エネルギー必要型エキソヌクレアーゼ、ATP産生エネルギー不必要型エキソヌクレアーゼ）、用途別市場規模（バイオテクノロジー企業、製薬企業、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・エキソヌクレアーゼの市場動向 ・企業の競争状況、市場シェア ・エキソヌクレアーゼの種類別市場規模と予測2016-2027（ATP産生エネルギー必要型エキソヌクレアーゼ、ATP産生エネルギー不必要型エキソヌクレアーゼ） ・エキソヌクレアーゼの用途別市場規模と予測2016-2027（バイオテクノロジー企業、製薬企業、その他） ・エキソヌクレアーゼの北米市場規模2016-2027（アメリカ、カナダ） ・エキソヌクレアーゼの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・エキソヌクレアーゼのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エキソヌクレアーゼの中南米市場規模2016-2027（メキシコ、ブラジル） ・エキソヌクレアーゼの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（QIAGEN、New England Biolabs、Roche、Thermo Fisher Scientific、Takara、Agilent、Illumina） ・結論 |
Endonuclease is one of the type of nucleases which cut off nucleic acids from the middle. Exonucleases are the enzymes which breaks the nucleic acid by removing nucleotides from the end of the chain.
Market Analysis and Insights: Global Exonucleases Market
The global Exonucleases market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exonucleases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exonucleases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exonucleases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exonucleases market.
Global Exonucleases Scope and Market Size
Exonucleases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Exonucleases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Exonucleases Needing ATP Provinding Energy
Exonucleases Not Needing ATP Provinding Energy
Segment by Application
Biotechnological Companies
Pharmaceutical Companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
QIAGEN
New England Biolabs
Roche
Thermo Fisher Scientific
Takara
Agilent
Illumina
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exonucleases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Exonucleases Needing ATP Provinding Energy
1.2.3 Exonucleases Not Needing ATP Provinding Energy
1.3 Market by Application
1.3.1 Global Exonucleases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biotechnological Companies
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Exonucleases Market Perspective (2016-2027)
2.2 Exonucleases Growth Trends by Regions
2.2.1 Exonucleases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Exonucleases Historic Market Share by Regions (2016-2021)
2.2.3 Exonucleases Forecasted Market Size by Regions (2022-2027)
2.3 Exonucleases Industry Dynamic
2.3.1 Exonucleases Market Trends
2.3.2 Exonucleases Market Drivers
2.3.3 Exonucleases Market Challenges
2.3.4 Exonucleases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exonucleases Players by Revenue
3.1.1 Global Top Exonucleases Players by Revenue (2016-2021)
3.1.2 Global Exonucleases Revenue Market Share by Players (2016-2021)
3.2 Global Exonucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Exonucleases Revenue
3.4 Global Exonucleases Market Concentration Ratio
3.4.1 Global Exonucleases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exonucleases Revenue in 2020
3.5 Exonucleases Key Players Head office and Area Served
3.6 Key Players Exonucleases Product Solution and Service
3.7 Date of Enter into Exonucleases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exonucleases Breakdown Data by Type
4.1 Global Exonucleases Historic Market Size by Type (2016-2021)
4.2 Global Exonucleases Forecasted Market Size by Type (2022-2027)
5 Exonucleases Breakdown Data by Application
5.1 Global Exonucleases Historic Market Size by Application (2016-2021)
5.2 Global Exonucleases Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Exonucleases Market Size (2016-2027)
6.2 North America Exonucleases Market Size by Type
6.2.1 North America Exonucleases Market Size by Type (2016-2021)
6.2.2 North America Exonucleases Market Size by Type (2022-2027)
6.2.3 North America Exonucleases Market Size by Type (2016-2027)
6.3 North America Exonucleases Market Size by Application
6.3.1 North America Exonucleases Market Size by Application (2016-2021)
6.3.2 North America Exonucleases Market Size by Application (2022-2027)
6.3.3 North America Exonucleases Market Size by Application (2016-2027)
6.4 North America Exonucleases Market Size by Country
6.4.1 North America Exonucleases Market Size by Country (2016-2021)
6.4.2 North America Exonucleases Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Exonucleases Market Size (2016-2027)
7.2 Europe Exonucleases Market Size by Type
7.2.1 Europe Exonucleases Market Size by Type (2016-2021)
7.2.2 Europe Exonucleases Market Size by Type (2022-2027)
7.2.3 Europe Exonucleases Market Size by Type (2016-2027)
7.3 Europe Exonucleases Market Size by Application
7.3.1 Europe Exonucleases Market Size by Application (2016-2021)
7.3.2 Europe Exonucleases Market Size by Application (2022-2027)
7.3.3 Europe Exonucleases Market Size by Application (2016-2027)
7.4 Europe Exonucleases Market Size by Country
7.4.1 Europe Exonucleases Market Size by Country (2016-2021)
7.4.2 Europe Exonucleases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Exonucleases Market Size (2016-2027)
8.2 Asia-Pacific Exonucleases Market Size by Type
8.2.1 Asia-Pacific Exonucleases Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Exonucleases Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Exonucleases Market Size by Type (2016-2027)
8.3 Asia-Pacific Exonucleases Market Size by Application
8.3.1 Asia-Pacific Exonucleases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Exonucleases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Exonucleases Market Size by Application (2016-2027)
8.4 Asia-Pacific Exonucleases Market Size by Region
8.4.1 Asia-Pacific Exonucleases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Exonucleases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Exonucleases Market Size (2016-2027)
9.2 Latin America Exonucleases Market Size by Type
9.2.1 Latin America Exonucleases Market Size by Type (2016-2021)
9.2.2 Latin America Exonucleases Market Size by Type (2022-2027)
9.2.3 Latin America Exonucleases Market Size by Type (2016-2027)
9.3 Latin America Exonucleases Market Size by Application
9.3.1 Latin America Exonucleases Market Size by Application (2016-2021)
9.3.2 Latin America Exonucleases Market Size by Application (2022-2027)
9.3.3 Latin America Exonucleases Market Size by Application (2016-2027)
9.4 Latin America Exonucleases Market Size by Country
9.4.1 Latin America Exonucleases Market Size by Country (2016-2021)
9.4.2 Latin America Exonucleases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exonucleases Market Size (2016-2027)
10.2 Middle East & Africa Exonucleases Market Size by Type
10.2.1 Middle East & Africa Exonucleases Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Exonucleases Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Exonucleases Market Size by Type (2016-2027)
10.3 Middle East & Africa Exonucleases Market Size by Application
10.3.1 Middle East & Africa Exonucleases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Exonucleases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Exonucleases Market Size by Application (2016-2027)
10.4 Middle East & Africa Exonucleases Market Size by Country
10.4.1 Middle East & Africa Exonucleases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Exonucleases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Details
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Exonucleases Introduction
11.1.4 QIAGEN Revenue in Exonucleases Business (2016-2021)
11.1.5 QIAGEN Recent Development
11.2 New England Biolabs
11.2.1 New England Biolabs Company Details
11.2.2 New England Biolabs Business Overview
11.2.3 New England Biolabs Exonucleases Introduction
11.2.4 New England Biolabs Revenue in Exonucleases Business (2016-2021)
11.2.5 New England Biolabs Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Exonucleases Introduction
11.3.4 Roche Revenue in Exonucleases Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Exonucleases Introduction
11.4.4 Thermo Fisher Scientific Revenue in Exonucleases Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Takara
11.5.1 Takara Company Details
11.5.2 Takara Business Overview
11.5.3 Takara Exonucleases Introduction
11.5.4 Takara Revenue in Exonucleases Business (2016-2021)
11.5.5 Takara Recent Development
11.6 Agilent
11.6.1 Agilent Company Details
11.6.2 Agilent Business Overview
11.6.3 Agilent Exonucleases Introduction
11.6.4 Agilent Revenue in Exonucleases Business (2016-2021)
11.6.5 Agilent Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Exonucleases Introduction
11.7.4 Illumina Revenue in Exonucleases Business (2016-2021)
11.7.5 Illumina Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Exonucleases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Exonucleases Needing ATP Provinding Energy
Table 3. Key Players of Exonucleases Not Needing ATP Provinding Energy
Table 4. Global Exonucleases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Exonucleases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Exonucleases Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Exonucleases Market Share by Regions (2016-2021)
Table 8. Global Exonucleases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Exonucleases Market Share by Regions (2022-2027)
Table 10. Exonucleases Market Trends
Table 11. Exonucleases Market Drivers
Table 12. Exonucleases Market Challenges
Table 13. Exonucleases Market Restraints
Table 14. Global Exonucleases Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Exonucleases Market Share by Players (2016-2021)
Table 16. Global Top Exonucleases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exonucleases as of 2020)
Table 17. Ranking of Global Top Exonucleases Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Exonucleases Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Exonucleases Product Solution and Service
Table 21. Date of Enter into Exonucleases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exonucleases Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Exonucleases Revenue Market Share by Type (2016-2021)
Table 25. Global Exonucleases Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Exonucleases Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Exonucleases Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Exonucleases Revenue Market Share by Application (2016-2021)
Table 29. Global Exonucleases Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Exonucleases Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Exonucleases Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Exonucleases Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Exonucleases Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Exonucleases Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Exonucleases Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Exonucleases Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Exonucleases Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Exonucleases Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Exonucleases Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Exonucleases Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Exonucleases Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Exonucleases Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Exonucleases Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Exonucleases Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Exonucleases Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Exonucleases Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Exonucleases Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Exonucleases Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Exonucleases Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Exonucleases Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Exonucleases Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Exonucleases Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Exonucleases Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Exonucleases Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Exonucleases Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Exonucleases Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Exonucleases Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Exonucleases Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Exonucleases Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Exonucleases Market Size by Country (2022-2027) & (US$ Million)
Table 61. QIAGEN Company Details
Table 62. QIAGEN Business Overview
Table 63. QIAGEN Exonucleases Product
Table 64. QIAGEN Revenue in Exonucleases Business (2016-2021) & (US$ Million)
Table 65. QIAGEN Recent Development
Table 66. New England Biolabs Company Details
Table 67. New England Biolabs Business Overview
Table 68. New England Biolabs Exonucleases Product
Table 69. New England Biolabs Revenue in Exonucleases Business (2016-2021) & (US$ Million)
Table 70. New England Biolabs Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Exonucleases Product
Table 74. Roche Revenue in Exonucleases Business (2016-2021) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Exonucleases Product
Table 79. Thermo Fisher Scientific Revenue in Exonucleases Business (2016-2021) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Takara Company Details
Table 82. Takara Business Overview
Table 83. Takara Exonucleases Product
Table 84. Takara Revenue in Exonucleases Business (2016-2021) & (US$ Million)
Table 85. Takara Recent Development
Table 86. Agilent Company Details
Table 87. Agilent Business Overview
Table 88. Agilent Exonucleases Product
Table 89. Agilent Revenue in Exonucleases Business (2016-2021) & (US$ Million)
Table 90. Agilent Recent Development
Table 91. Illumina Company Details
Table 92. Illumina Business Overview
Table 93. Illumina Exonucleases Product
Table 94. Illumina Revenue in Exonucleases Business (2016-2021) & (US$ Million)
Table 95. Illumina Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exonucleases Market Share by Type: 2020 VS 2027
Figure 2. Exonucleases Needing ATP Provinding Energy Features
Figure 3. Exonucleases Not Needing ATP Provinding Energy Features
Figure 4. Global Exonucleases Market Share by Application: 2020 VS 2027
Figure 5. Biotechnological Companies Case Studies
Figure 6. Pharmaceutical Companies Case Studies
Figure 7. Others Case Studies
Figure 8. Exonucleases Report Years Considered
Figure 9. Global Exonucleases Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Exonucleases Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Exonucleases Market Share by Regions: 2020 VS 2027
Figure 12. Global Exonucleases Market Share by Regions (2022-2027)
Figure 13. Global Exonucleases Market Share by Players in 2020
Figure 14. Global Top Exonucleases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exonucleases as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Exonucleases Revenue in 2020
Figure 16. Global Exonucleases Revenue Market Share by Type (2016-2021)
Figure 17. Global Exonucleases Revenue Market Share by Type (2022-2027)
Figure 18. North America Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Exonucleases Market Share by Type (2016-2027)
Figure 20. North America Exonucleases Market Share by Application (2016-2027)
Figure 21. North America Exonucleases Market Share by Country (2016-2027)
Figure 22. United States Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Exonucleases Market Share by Type (2016-2027)
Figure 26. Europe Exonucleases Market Share by Application (2016-2027)
Figure 27. Europe Exonucleases Market Share by Country (2016-2027)
Figure 28. Germany Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Exonucleases Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Exonucleases Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Exonucleases Market Share by Region (2016-2027)
Figure 38. China Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Exonucleases Market Share by Type (2016-2027)
Figure 46. Latin America Exonucleases Market Share by Application (2016-2027)
Figure 47. Latin America Exonucleases Market Share by Country (2016-2027)
Figure 48. Mexico Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Exonucleases Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Exonucleases Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Exonucleases Market Share by Country (2016-2027)
Figure 54. Turkey Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Exonucleases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. QIAGEN Revenue Growth Rate in Exonucleases Business (2016-2021)
Figure 58. New England Biolabs Revenue Growth Rate in Exonucleases Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Exonucleases Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Exonucleases Business (2016-2021)
Figure 61. Takara Revenue Growth Rate in Exonucleases Business (2016-2021)
Figure 62. Agilent Revenue Growth Rate in Exonucleases Business (2016-2021)
Figure 63. Illumina Revenue Growth Rate in Exonucleases Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の電気エネルギー貯蔵（EES）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Electrical Energy Storage(EES) Market The global Electrical Energy Storage(EES) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…- 世界の代替エネルギー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alternative Energy Market The global Alternative Energy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界のエネルギーベース肌引き締め市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Energy-based Skin Tightening Market The global Energy-based Skin Tightening market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
- 世界の浸透圧エネルギー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Osmotic Energy Market The global Osmotic Energy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 世界の分散型エネルギーシステム市場規模・現状・予測（2021年-2027年） A decentralized energy system is characterized by locating of energy production facilities closer to the site of energy consumption. A decentralized energy systemallows for more optimal use of renewable energy as well as combined heat andpower, reduces fossil fuel use and increases eco-efficiency. M…